Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection

Clinical and Experimental Immunology

Volumn 109, Issue 3, 1997, Pages 451-457

  Corado, J ^a   Toro, F ^a   Rivera, H ^a   Bianco, N E ^a   Deibis, L ^a   De Sanctis, J B ^a,b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Instituto de Oncologia y Hematologia   (United States)

Author keywords

Cytotoxicity; Hepatitis C virus; IL 2; Infection; Lymphokine activated killer cells; Natural killer cells

Indexed keywords

INTERLEUKIN 2;

ADHERENT CELL; ADULT; ARTICLE; B LYMPHOCYTE; CELL SUBPOPULATION; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; LYMPHOKINE ACTIVATED KILLER CELL; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0030867688     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4581355.x     Document Type: Article

References (28)

1. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14:969-74.
2. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14:381-8.
3. Botarelli P, Brunetto MR, Minutello MA et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104:580-7.
4. Farci P, Alter HJ, Govindarajan S et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 256:135-40.
5. Spengler U, Lechmann M, Irrgang B, Dumoulin FL, Sauerbruch T. Immune response in hepatitis C virus infection. J Hepatol 1996; 24:20-25.
6. + T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993; 178:17-25.
7. Schupper HP, Scheffel HJ, Aceituno S, Paglieroni T, Holland PV, Zeldis JB. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigen in patients with chronic hepatitis C. Hepatology 1993; 18:1055-60.
8. Cerny A, McHutchison JG, Pasquinelli C et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2-1 binding motif. J Clin Invest 1995; 95:521-30.
9. Corado JA, Toro FI, Baroja ML, Bianco NE, Machado IV. CD3 and CD28 activating pathways in HCV infection. Viral Immunol 1994; 7:37-40.
10. Whiteside TL, Herberman RB. Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol 1994; 1:125-33.
11. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47:187-376.
12. Hata K, Van Thiel DH, Heberman RB, Whiteside TL. Natural killer activity of human liver-derived lymphocytes in various hepatic diseases. Hepatology 1991; 14:495-503.
13. Inchauspe G, Abe K, Zebedee S, Nasoff M, Prince AM. Use of conserved sequences from hepatitis C vims for the detection of viral RNA in infected sera by polymerase chain reaction. Hepatology 1991; 14:595-600.
14. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73:673-9.
15. Caldera LH, León-Ponte M, Acquatella G, Bianco NE, Blanca I. Bone marrow and peripheral blood natural killer cell activity in lymphomas. Its response to IL-2. Clin Exp Immunol 1992; 88:143-50.
16. Biron C, Byron KS, Sullivan J. Severe herpes virus infection in an adolescent without natural killer cells. N Engl J Med 1989; 30:1731-5.
17. de la Torre JC, Oldstone MBA. Anatomy of viral persistence: mechanisms of persistence and associated disease. Adv Virus Res 1996; 46:311-43.
18. Iino S, Hino K, Yasuda K. Current state of interferon therapy for chronic hepatitis C. Intervirology 1994; 37:87-100.
19. McFarlanc IG. Autoimmunity and hepatotropic viruses. Sem Liver Dis 1991; 11:223-33.
20. Gerber MA. Pathobiologic effects of hepatitis C. J Hepatol 1995; 22:83-86.
21. Zignego AL, Maccha D, Monti M et al. Infection of peripheral blood mononuclear cells by hepatitis C. J Hepatol 1992; 15:382-6.
22. Müller HM, Pfaff E, Goeser T, Kallinowski B, Solbach C, Theilman L. Peripheral blood leucocytes as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol 1993; 74:669-76.
23. Cribier B, Schmitt C, Bringen A, Kim A, Keller F. In vitro infection of peripheral blood mononuclear cells by hepatitis C virus. J Gen Virol 1995; 76:2485-91.
24. Wang JT, Sheu JC, Lin JT, Wang TH, Chen DS. Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis 1992; 166:1167-9.
25. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H. Evidence for in vitro replication in a human T-cell line. Proc Natl Acad Sci USA 1992; 89:5477-81.
26. Bertolini L, Iacovacci S, Ponzetto A, Gorini G, Battaglia M, Carlini G. The human bone-marrow-derived cell line CE, susceptible to hepatitis C virus infection. Res Virol 1993; 144:281-5.
27. Casali P, Rice GPA, Oldstone MBA. Viruses disrupt function of human lymphocytes. Effects of measles virus and influenza virus on lymphocyte-mediated killing and antibody production. J Exp Med 1984; 159:1322-37.
28. Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996; 117:86-91.